Pharming reports Phase II data for Ruconest in HAE in pediatric patients

By Claire Quang | Nov 30, 2017 | 11:25 PM GMT

In September, Pharming Group N.V. (Euronext:PHARM) reported data from 20 patients ages 2-13 with hereditary angioedema (HAE)

Read the full 179 word article

How to gain access

Continue reading with a
two-week free trial.